ArticleFrontiers in oncology2021

AGIG Chemo-Immunotherapy in Patients With Advanced Pancreatic Cancer: A Single-Arm, Single-Center, Phase 2 Study.

Wangshu Dai et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.